Use of Angiotensin Converting Enzyme Inhibitors and Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer

被引：0

作者：

Kerns, S. L. ^{[1
]}

Morlang, A. ^{[1
]}

Lee, S. M. ^{[2
]}

Hall, W. A. ^{[3
]}

Peterson, D. ^{[4
]}

Marples, B. ^{[1
]}

Zhang, H. ^{[1
]}

Bylund, K. C. ^{[1
]}

Rosenzweig, D. ^{[1
]}

de Ruyck, K. ^{[5
]}

Rosenstein, B. S. ^{[6
]}

Gomez CaamaNo, A. ^{[7
]}

Vega, A. ^{[8
]}

Parker, C. ^{[9
,10
]}

West, C. M. L. ^{[11
]}

Janelsins, M. ^{[12
]}

Chen, Y. ^{[1
]}

Messing, E. ^{[13
]}

Morrow, G. ^{[12
]}

机构：

[1] Univ Rochester, Dept Radiat Oncol, Rochester, NY USA

[2] Univ Rochester, Rochester, NY USA

[3] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA

[4] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA

[5] Univ Ghent, Ghent, Belgium

[6] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY USA

[7] H Clin Univ, Santiago De Compostela, Spain

[8] Univ Santiago de Compostela, Santiago De Compostela, Spain

[9] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England

[10] Inst Canc Res, Sutton, Surrey, England

[11] Univ Manchester, Manchester, Lancs, England

[12] Univ Rochester, Dept Surg, Canc Control, Rochester, NY USA

[13] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2566

引用

页码：E280 / E281

页数：2

共 50 条

[31] Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations
Bateman, Brian T.
Patorno, Elisabetta
Desai, Rishi J.
Seely, Ellen W.
Mogun, Helen
Dejene, Sara Z.
Fischer, Michael A.
Friedman, Alexander M.
Hernandez-Diaz, Sonia
Huybrechts, Krista F.
OBSTETRICS AND GYNECOLOGY, 2017, 129 (01): : 174 - 184
[32] Angioedema and angiotensin-converting enzyme inhibitors: Are demographics a risk?
Mahoney, Elizabeth J.
Devaiah, Anand K.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2008, 139 (01) : 105 - 108
[33] Angiotensin-converting enzyme inhibitors and angioedema - Estimating the risk
Weber, Michael A.
Messerli, Franz H.
HYPERTENSION, 2008, 51 (06) : 1465 - 1467
[34] HYPOGLYCEMIA ASSOCIATED WITH USE OF INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME
HERINGS, RMC
DEBOER, A
STRICKER, BHC
LEUFKENS, HGM
PORSIUS, A
LANCET, 1995, 345 (8959): : 1195 - 1198
[35] The use of angiotensin-converting enzyme inhibitors in general medicine
Mashitisho, M. L., I
SOUTH AFRICAN FAMILY PRACTICE, 2012, 54 (04) : 313 - 315
[36] PRACTICAL USE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
ZSCHIEDRICH, H
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1993, 43-1 (2A): : 271 - 273
[37] Use of aspirin in patients taking angiotensin converting enzyme inhibitors
Altin, Timucin
Kilickap, Mustafa
ANATOLIAN JOURNAL OF CARDIOLOGY, 2007, 7 : 14 - 19
[38] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS - WHEN TO USE
HAMPTON, JR
COWLEY, AJ
CARDIOLOGY, 1988, 75 : 118 - 125
[39] Additional contraindication to use of angiotensin-converting-enzyme inhibitors
Segars, LW
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (13) : 1552 - 1552
[40] Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies
Yoon, Chan
Yang, Hyun-Sik
Jeon, Inpyo
Chang, Yoosoo
Park, Sang Min
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (14) : E1073 - E1084

← 1 2 3 4 5 →